| Identification | Back Directory | [Name]
Nafoxidine | [CAS]
1847-63-8 | [Synonyms]
CP-56
11100A
CP-5600
U 11100
U-11100A
Nafoxiden
NSC-70735
PNU-0011100
Nafoxidine HCl
Nafoxidene hydrochloride
Nafoxidine HCl（1845-11-0 Free base）
1-[2-[p-(3,4-dihydro-6-Methoxy-2-phenyl-1-naphthyl)phenoxy]ethyl]pyrrolidine Hydrochloride
1-[2-[4-(3,4-dihydro-6-Methoxy-2-phenyl-1-naphthalenyl)phenoxy]ethyl]pyrrolidine Hydrochloride
1-(2-(4-(6-Methoxy-2-phenyl-3,4-dihydronaphthalen-1-yl)phenoxy)ethyl)pyrrolidine hydrochloride
Pyrrolidine,1-[2-[4-(3,4-dihydro-6-methoxy-2-phenyl-1-naphthalenyl)phenoxy]ethyl]-,hydrochloride (1:1) | [Molecular Formula]
C29H32ClNO2 | [MDL Number]
MFCD00056572 | [MOL File]
1847-63-8.mol | [Molecular Weight]
462.023 |
| Chemical Properties | Back Directory | [Melting point ]
165-168℃ | [storage temp. ]
room temp | [solubility ]
H2O: ≥8mg/mL | [form ]
powder | [color ]
white to tan | [Water Solubility ]
H2O: ≥8mg/mL |
| Hazard Information | Back Directory | [Chemical Properties]
Off-White Solid | [Uses]
Nafoxidine is a non-steroidal antiestrogenic drug that is structurally related to Tamoxifen (T006000). Nafoxidine is a potent estrogen receptor antagonist that exhibits anti-proliferative properties. | [Biological Activity]
Nafoxidine is a potent estrogen receptor antagonist th at exhibits anti-proliferative properties. It is a non-steroidal antiestrogena derivative of Tamoxifen. |
|
| Company Name: |
BePharm Ltd
|
| Tel: |
400-685-9117 |
| Website: |
www.bepharm.com |
|